TNFα-Based Isolated Perfusion for Limb-Threatening Soft Tissue Sarcomas: State of the Art and Future Trends
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 26 (4) , 291-300
- https://doi.org/10.1097/00002371-200307000-00001
Abstract
The management of limb-threatening soft tissue sarcomas has not yet been standardized. Although local disease control does not affect overall survival, amputation or highly mutilating surgery may be required, which impairs the patient's quality of life. Various neoadjuvant approaches have been proposed to allow limb-sparing surgery for these locally advanced tumors. With TNFα-based hyperthermic isolated limb perfusion, the majority of patients can be spared amputation, with acceptable rates of locoregional and systemic complications. As yet, no other available treatment seems to give comparable results when applied to limb-threatening soft tissue sarcomas. Nevertheless, several issues remain to be addressed, such as the type and dose of drugs, repeatability of the procedure, association with radiotherapy, further indications, and evaluation of response. The authors describe the principles underlying TNFα-based hyperthermic isolated limb perfusion, review the worldwide experience so far published, and discuss the above issues. The potential future developments of this locoregional therapeutic approach will also be reported.Keywords
This publication has 98 references indexed in Scilit:
- Systemic Toxicity and Cytokine/Acute Phase Protein Levels in Patients After Isolated Limb Perfusion With Tumor Necrosis Factor-a Complicated by High LeakageAnnals of Surgical Oncology, 2000
- Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-? and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological ConsiderationsAnnals of Surgical Oncology, 2000
- Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremityEuropean Journal of Surgical Oncology, 1999
- Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing ratsInternational Journal of Cancer, 1998
- Rhabdomyolysis and renal function impairment after isolated limb perfusion—Comparison between the effects of perfusion with rhTNFα and a ‘triple-drug’ regimenEuropean Journal Of Cancer, 1997
- Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and long-term functional resultsEuropean Journal Of Cancer, 1994
- Local control of soft tissue sarcoma of the extremity: The experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapyEuropean Journal Of Cancer, 1994
- Phase I study of intratumoral application of recombinant human tumor necrosis factorEuropean Journal of Cancer and Clinical Oncology, 1989
- Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactionsEuropean Journal of Cancer and Clinical Oncology, 1982
- The Management of Locally Recurrent Soft-Tissue SarcomaAnnals of Surgery, 1982